Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
69,201,978
-
Share change
-
+1,089,418
-
Total reported value
-
$5,105,524,096
-
Put/Call ratio
-
28%
-
Price per share
-
$73.78
-
Number of holders
-
359
-
Value change
-
+$80,718,400
-
Number of buys
-
174
-
Number of sells
-
146
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2022
As of 31 Mar 2022,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
359 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,201,978 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Capital Research Global Investors, RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, and AXA S.A..
This page lists
364
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.